InsidersTradesSigma
Follow the 아이오바이오 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 아이오바이오 has published 10 reports. The latest transaction was filed on 8 July 2026 (Other). Among the most active insiders: DSC인베스트먼트. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
10 of 10 declarations
아이오바이오 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions for the medical sector.